Alnylam Pharmaceuticals
ALNY
#606
Rank
โ‚น2.836 T
Marketcap
โ‚น21,993
Share price
-1.49%
Change (1 day)
60.20%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company